St Jude hopes of Amplazter PFO approval dented after RESPECT falls short
This article was originally published in Clinica
Executive Summary
US FDA approval of St Jude Medical's percutaneous Amplatzer patent foramen ovale (PFO) closure device has been thrown into doubt after a study showed that it was no more effective than drug therapy in preventing stroke.